AU2003269478A1 - A novel process for amorphous rosuvastatin calcium - Google Patents
A novel process for amorphous rosuvastatin calciumInfo
- Publication number
- AU2003269478A1 AU2003269478A1 AU2003269478A AU2003269478A AU2003269478A1 AU 2003269478 A1 AU2003269478 A1 AU 2003269478A1 AU 2003269478 A AU2003269478 A AU 2003269478A AU 2003269478 A AU2003269478 A AU 2003269478A AU 2003269478 A1 AU2003269478 A1 AU 2003269478A1
- Authority
- AU
- Australia
- Prior art keywords
- novel process
- rosuvastatin calcium
- amorphous rosuvastatin
- amorphous
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229960004796 rosuvastatin calcium Drugs 0.000 title 1
- LALFOYNTGMUKGG-BGRFNVSISA-L rosuvastatin calcium Chemical compound [Ca+2].CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O.CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O LALFOYNTGMUKGG-BGRFNVSISA-L 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2003/000288 WO2005021511A1 (en) | 2003-08-27 | 2003-08-27 | A novel process for amorphous rosuvastatin calcium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003269478A1 true AU2003269478A1 (en) | 2005-03-16 |
Family
ID=34259913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003269478A Abandoned AU2003269478A1 (en) | 2003-08-27 | 2003-08-27 | A novel process for amorphous rosuvastatin calcium |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003269478A1 (en) |
| WO (1) | WO2005021511A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1562912A2 (en) | 2003-08-28 | 2005-08-17 | Teva Pharmaceutical Industries Limited | Process for preparation of rosuvastatin calcium |
| US7777034B2 (en) | 2003-11-24 | 2010-08-17 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
| WO2005056534A1 (en) | 2003-12-02 | 2005-06-23 | Teva Pharmaceutical Industries Ltd. | Reference standard for characterization of rosuvastatin |
| EP1737828A1 (en) * | 2004-01-19 | 2007-01-03 | Ranbaxy Laboratories Limited | Amorphous magnesium salts of rosuvastatin |
| KR100945763B1 (en) | 2005-02-22 | 2010-03-08 | 테바 파마슈티컬 인더스트리즈 리미티드 | How to prepare rosuvastatin |
| EP1805148A2 (en) | 2005-08-16 | 2007-07-11 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
| HU227610B1 (en) * | 2006-09-18 | 2011-09-28 | Richter Gedeon Nyrt | Pharmaceutical compositions containing rosuvastatin potassium |
| BRPI0706062A2 (en) | 2006-09-18 | 2011-03-22 | Teva Pharma | crystalline calcium rosuvastatin |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2648897B2 (en) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | Pyrimidine derivatives |
| GB0003305D0 (en) * | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
| BR0311195A (en) * | 2002-05-21 | 2005-02-22 | Ranbaxy Lab Ltd | Rosuvastatin Preparation Process |
-
2003
- 2003-08-27 AU AU2003269478A patent/AU2003269478A1/en not_active Abandoned
- 2003-08-27 WO PCT/IN2003/000288 patent/WO2005021511A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005021511A1 (en) | 2005-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003299670A1 (en) | Process for producing a liquid crystalline polymer | |
| IL187578A0 (en) | Process for preparing pure amorphous rosuvastatin calcium | |
| AU2003901583A0 (en) | A process | |
| AU2003278406A1 (en) | Amorphous form of esomeprazole salts | |
| ZA200702965B (en) | Process for forming amorphous atorvastatin | |
| AU2003282384A1 (en) | A novel process for ezetimibe intermediate | |
| AU2003283870A1 (en) | Process for preparing a composition | |
| AU2003269478A1 (en) | A novel process for amorphous rosuvastatin calcium | |
| HU0300761D0 (en) | Process for the production of amorphous atorvastatin calcium | |
| AU2003230195A1 (en) | A novel process for amorphous form of donepezil hydrochloride | |
| AU2003275064A1 (en) | Optimal crystallization parameter determination process | |
| AU2003227510A1 (en) | Novel carbapenem compounds | |
| AU2003223106A1 (en) | A novel amorphous form of valsartan | |
| GB0314149D0 (en) | Novel amorphous forms | |
| AU2002356423A1 (en) | Process for the preparation of amorphous atorvastatin calcium | |
| AU2003211227A1 (en) | Process for producing azetidinone compounds | |
| IL178574A0 (en) | Process for forming amorphous atorvastatin calcium | |
| AU2003245982A1 (en) | Process for preparing styrene | |
| AU2003221374A1 (en) | Process for producing paper | |
| AU2003251467A1 (en) | Device for producing moulded bricks | |
| AU2003263743A1 (en) | Process for making a thermoplastic vulcanizates | |
| AU2003902807A0 (en) | A process for treating dust | |
| AU2002953499A0 (en) | Process for purifying inorganic materials | |
| AU2003292772A1 (en) | PROCESS FOR PRODUCING PNPase | |
| AU2003269406A1 (en) | Process for preparing s-(2-aminoethyl)-2-methyl-l-cysteine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |